Cardiac Perforation Caused by Cement Embolus After Total Hip Replacement


A 77-year-old woman was transferred to our hospital with persistent chest pain. She had no previous history of coronary heart disease. Two months earlier, she had undergone a complication-free hip replacement surgery with a cemented prosthesis.

On admission, she was nearly asymptomatic, but because of elevated cardiac troponin and ST-segment elevation in the inferior and lateral leads, a coronary angiography was performed, which showed normal coronary arteries. However, fluoroscopy revealed a thin, opaque structure apparently overlying the heart. After 2 hours of observation, signs and symptoms of pericarditis were noted, and shortly thereafter, worsening ensued with progression to cardiac tamponade. After percutaneous evacuation of 250 mL blood from the pericardial cavity, her clinical condition normalized. A computed tomography scan was performed to rule out aortic dissection. The computed tomography scan and an echocardiogram confirmed the presence of a hyperechogenic rod-like structure perforating the wall of the right atrium (Figure 1A and 1B). Open heart surgery was performed the following morning.

Figure 1.

A, Thoracic computed tomography scan of the heart. The green arrow shows the cement embolus; red arrow, the pigtail catheter inserted during pericardiocentesis. B, An echocardiogram showing a hyperechogenic rod-like structure within the right side of the heart (green arrow). Ao indicates aorta; LV, left ventricle; RA, right atrium; and RV, right ventricle.

After opening of the pericardium, which was found to be markedly inflamed, a foreign object penetrating the right auricle was removed, and the defect in the wall was repaired.

The foreign object was 54 mm long and ≈1.5 mm wide (Figure 2A). Because the patient had undergone hip replacement surgery 2 months previously, it was suspected that the foreign object could represent a cement embolus. To confirm the nature of the object, a small piece was cut off and subjected to field emission scanning electron microscopy (Figure 2B). A piece of Palacos bone cement was used as control (Figure 2C). The structures of the foreign object and the control bone cement were identical, confirming that the foreign object was in fact a bone cement embolus to the heart. The patient made an uneventful recovery.

Figure 2.

A, A macroscopic picture of the foreign object after removal from the patient. B, A scanning electron microscopy (SEM) image of the foreign object. C, An image of the corresponding control bone cement. A Zeiss Sigma Field Emission SEM microscope with an SE2 detector and high voltage was used.

Discussion

Cement or polymethylmethacrylate is widely used in hip and knee replacement surgery. Cement is also used in vertebroplasty and kyphoplasty when vertebral compression fractures are treated percutaneously.1

Although these procedures are considered safe, serious complications may occur. One of the most feared complications after vertebroplasty or kyphoplasty procedures results from extravasations of cement into the vertebral venous circulation.24 The cement may migrate through the iliolumbar and epidural veins centrally toward the chambers and pulmonary arteries of the right side of the heart. Although cement embolism is often asymptomatic, more severe pulmonary embolism and cardiac perforation may result.

To the best of our knowledge, this is the first report of a patient who presented with a cement embolus to the right heart after total hip replacement. We suggest that extravasation of cement into the venous system occurred during the insertion of the prosthesis, quite analogous to what may happen during kyphoplasty procedures. Like a cast from the involved vein, the cement fragment migrates to the right heart.

Although extremely rare, cement embolization to the heart should be considered in patients presenting with chest pain after hip replacement surgery in which cemented prostheses are used. The patient gave consent to publication.

Can DNA evidence fill gaps in our history books?


If you go back far enough, all people share a common ancestry. But some populations are more closely related than others based on events in the past that brought them together. Now, researchers have shown that it’s possible to use DNA evidence as a means to reconstruct and date those significant past events. The findings suggest that evidence in our genomes can help to recover lost bits of history.

Gene flow within West Eurasia is shown by lines linking the best-matching donor group to the sources of admixture with recipient clusters (arrowhead). Line colors represent the regional identity of the donor group, and line thickness represents the proportion of DNA coming from the donor group. Ranges of the dates (point estimates) for events involving sources most similar to selected donor groups are shown.

If you go back far enough, all people share a common ancestry. But some populations are more closely related than others based on events in the past that brought them together. Now, researchers reporting in the Cell Press journal Current Biologyon September 17 have shown that it’s possible to use DNA evidence as a means to reconstruct and date those significant past events. The findings suggest that evidence in our genomes can help to recover lost bits of history.

“We now have the statistical machinery to uncover which historical events have produced the mosaic genomes of people in Europe today,” says George Busby of the University of Oxford. “The successful reconstruction of the genetic history of a region of the world that has been well investigated both archaeologically and historically suggests that these approaches have the potential to be applied to areas where history has not been so well recorded and where genetics might be the only way of recovering history.”

Busby and his colleagues applied a new method they’ve developed to compare single genetic variants among populations, taking into account the relationships among those markers based on their physical proximity along the chromosomes. That information can be used to infer subtle relationships among populations, including those that are genetically very similar, as well as the history of a continent.

The new work shows that all European populations have mixed over time as people picked up and moved from one place to another. Usually this mixing has involved nearby groups, but sometimes populations bear the mark of invading populations from more distant locations.

“Much as different cultures have often borrowed elements from each other, we are now seeing that the genomes of people alive in Europe today contain ancestry from multiple different places, from within Europe and outside,” says Cristian Capelli, the study’s senior author.

The results offer interesting insights into human history, including the lives of “regular people.”

“History is often written by the winners and the elites–we often do not hear about the everyday life of people,” Busby says. “By studying the DNA of populations and understanding how different groups are ancestrally related to each other, our analysis tells the story of all people.”

For example, the researchers found evidence of contact across Central Asia with groups from Mongolia. In fact, they see evidence that Mongolians migrated into Europe in two waves: once at a time that matches the known expansions of Genghis Khan and the other occurring much earlier, prior to 1000 CE in groups of North East Europe, including the Chuvash, Russians, and Mordovians.

The researchers also see evidence of mixing among Europeans in the Mediterranean and people from West and North Africa at many times and places over the course of history. The Slavic expansion also left its mark on European genomes, showing that this was a key event in the genetic history of the region.

The researchers say it’s now “clear that migration and admixture have been the norm, rather than the exception, throughout human history.”

This New Technology Converts Sea Water Into Drinking Water In Minutes


Water is an essential to any human being on this planet, while having clean water is unfortunately not something we all have access to. But a new invention developed by a team of researchers at Alexandria University in Egypt could change that.

water_clean

The technology uses a desalination technique called pervaporation. Salt is removed from sea water using specifically designed synthetic membranes which filter out large salt particles and impurities so they can be evaporated away. The remaining salt is heated, vapourised, and condensed back into clean water.

 In developing countries, spending time and money on water filtration is important, but there aren’t always enough resources to properly explore the field. So when it comes to water cleaning in those countries, it’s important for technology to be affordable and easily replicable. Thankfully, the membranes involved in this new invention can be made in any lab using cheap materials that are available locally. More importantly, the vaporisation part of the process doesn’t require any electricity, making this method of water cleansing cheap and suitable for areas with no power supply.

Excitingly, researchers have discovered another cool feature of this technique  – not only does it filter out salt, it is capable of removing sewage and dirt as well. The breakthrough research was published in the journal Water Science and Technology.

“The technology implemented in the study is much better than reverse osmosis, the technology currently used in Egypt and most of the countries in the Middle East and North Africa,” Helmy El-Zanfaly, a professor of water contamination at Egypt’s National Research Centre, told Scidev.net. “It can effectively desalinate water with high concentration of salt like that of the Red Sea, where desalination costs more and yields less.”

Good news all around, but this prooduct is far from ready for consumer use. While the development is exciting and can certainly make a huge impact in years to come, a lot of work still needs to be done. The theories have been proven effective but large scale demonstration still needs to be done and an action plan for dealing with the waste also needs to be established.

In the meantime, to assist the some 750 million people across the globe who don’t have access to clean drinking water, you can donate to charities like Charity Water, who we have personally dealt with and raised over $5,000 for. Donate here.

14 Myths About Diabetes That Need To Be Busted Right Now!


Stop Believing These 14 Myths About Type 1 And Type 2 Diabetes

The cells in our body use glucose as fuel for energy. Insulin is the hormone that helps most the cells to convert glucose to energy. Diabetes can occur either if the body does not produce enough insulin to meet its needs, or if the insulin does not work properly. This results in high blood glucose levels. Over a period of time, high blood glucose levels can damage various tissues including the eyes, kidney, nerves, brain and heart. So here we throw light on some of the myths around type 1 and type 2 Diabetes and insulin.

# Myth 1: Only children and young adolescents develop type 1 diabetes.

Fact: Type 1 occurs most commonly in children between 7 to 13 years but it can occur in older age groups as well.

# Myth 2: Kids don’t get type 2 diabetes.

Fact: Although Type 2 Diabetes is usually diagnosed in adulthood, increasing obesity and changes in lifestyle have resulted in an increase in diabetes among young adults and even children.

# Myth 3: People who use insulin are unsafe drivers.

Fact: Diabetes need not affect driving. If you have diabetes, you should have your eyes checked regularly as recommended by your doctor. This will check for any damage to the retina (the back of the eye) or other changes that may affect driving. People on insulin should also check their finger prick blood glucose tests just before driving and, during longer drives, at least every 2 hours. You should discuss safe blood glucose ranges for driving with your doctor. You should keep glucose tablets (hypotab), glucose powder, or juice and some snacks in the car in case you have an episode of hypoglycaemia (low blood sugar).

# Myth 4: Once started, you have to be on insulin for ever.

Fact: People with type 2 diabetes may be started on short term insulin if they are unwell. Pregnant women may need it just for the duration of pregnancy. Insulin dosage is affected by several factors including type of diabetes, body weight, and other factors.

 # Myth 5: Oral medications are better than insulin.

Fact: People with type 1 diabetes will need insulin. For people with type 2 diabetes the decision on whether oral medicines or insulin is a better choice will depend on several factors including duration of diabetes, diabetes control, diabetes complications, and other health conditions.

# Myth 6: Insulin will result in weight gain.

Fact: Yes, Insulin and weight gain often go hand in hand, but weight control is essential and possible. If you have poorly controlled diabetes, before you start insulin, your body is unable to process glucose and use energy efficiently. Once you start insulin, your body uses the food you eat more efficiently and you gain weight. Therefore, it is critical to make lifestyle changes at the time you start insulin to minimize weight gain – it can be done!

# Myth 7: Women are more prone to diabetes.

Fact: Studies have indicated that Type I diabetes does not show a female bias. The overall sex ratio is roughly equal in children diagnosed under the age of 15. However, while populations with the highest incidence all show male excess, the lowest risk populations mostly of non-European origin, characteristically show a female bias.

# Myth 8: Diabetes is communicable.

Fact: We know diabetes is not contagious. It can’t be caught like a cold or flu. There seems to be some genetic link in diabetes, particularly type 2 diabetes. Lifestyle factors also play a part.

# Myth 9: Pre-Diabetes cannot be cured.

Fact: Early treatment can actually return blood glucose levels to the normal range. In fact, you will not develop type 2 diabetes automatically if you have pre-diabetes.

# Myth 10: Diabetes can be completely cured.

Fact: No. Cures for both type 1 and type 2 diabetes have proved elusive to medical science.

# Myth 11: Junk food and syrupy drinks don’t increase risk of Diabetes.

Fact: Obesity is a cause of diabetes. There is conclusive evidence that junk food is the leading cause of obesity and so junk food is also linked to diabetes. Soft drinks and junk food raise blood glucose and can provide several hundred calories in just one serving. A typical 300ml soft drink has 10 tsp of sugar and 40gms of carbohydrates.

Stop Believing These Myths About Type 1 And Type 2 Diabetes

# Myth 12: All artificial sweeteners are safe to consume.

FACT: Many artificial sweeteners contain a substance called aspartame, which is a sweetener for cold beverages and commonly used in many food products. However, it loses its sweetness at high temperature. For example, to sweeten one cup of hot tea or coffee we need more aspartame than to sweeten one cup of normal / cold water. So exercise caution in its use. Consuming more aspartame based sweeteners may cause abnormal functioning of the brain. Pregnant women, children and patients with advanced liver disease should avoid excess usage of aspartame. Opt for artificial sweeteners made of sucralose, which are safer and more stable in hot and cold conditions. Artificial sweeteners containing cyclamate are banned in most countries.

#13 Myth: Diabetics require multiple daily insulin injections

Fact: With the advent of modern day insulin, a patient has a variety of options to choose from. Either he/she can take an injection once a day or several times a day, depending on their case history and their doctor’s recommendations.

#14 Myth: Diabetics should not eat rice.

Fact: Diabetics can consume rice, but the quantity and quality always depends on the nature and degree of diabetes.

Overall the idea is to stay aware and informed about the symptoms and nature of diabetes. Do not neglect it. Even if you do not have any symptoms, the slow and silent damage to the organs may already be occurring. Consult your doctor. Stay informed. Stay Safe!

9 Things Only Type A People Will Understand


“He’s so Type A!” It’s something that we’ve all heard used to describe someone that is hardworking, demanding or extremely organized — and not always in a positive way. Now a fixture in pop-culture psychology, the concept has been around since the 1950s, when cardiologists Meyer Friedman and Ray Rosenman found a link between heart disease and what’s now identified as Type A personality. And while the stereotypes about this kind of person are easy to recognize, concrete criteria for who is and who isn’t Type A isn’t as clear-cut, especially for someone who is, let’s say, on the compulsive side. “You realize you’re a Type A person when you work with Type Bs — and vice versa,” says Michael Sanger, manager for Hogan Assessments, a company that provides personality assessments to businesses. “And true growth happens when you appreciate and learn from the other personality type.” Don’t know if you’re a Type A? Keep reading to see how many of these traits you identify with.

http://www.livestrong.com/slideshow/1011468-9-things-only-type-people-understand/?utm_source=newsletter&utm_medium=email&utm_campaign=0913_2nd_m

THIS ECOCAPSULE TINY HOME LETS YOU LIVE OFF-GRID ANYWHERE IN THE WORLD!


This egg-shaped abode is powered by solar and wind energy, includes rainwater collection and filtration, and even has a kitchenette that can be used to prepare a hot meal.

EcoCapsule1

Ambition to live off-grid does not come without its difficulties. First, there is the task of explaining to your friends and family members why you desire to detach from mainstream society and live peacefully in nature. And second, there are the logistics of how you might actually survivethe Earth’s fluctuating weather patterns while taking care of basic necessities like running water, a flushing toilet, or even a fire pit to cook food over.

But soon such woes may no longer be a concern, as an ingenious little egg-shaped tiny home has just been unveiled to the world with capabilities that  far surpass most other off-grid abodes.

Credit: Nice Architects

Credit: Nice Architects

Designed by Bratislava-based Nice Architects, the Ecocapsule is a micro-shelter that offers a variety of sustainable offerings. Ultra-portable, the capsule is powered by solar and wind energy, includes rainwater collection and filtration, and even has a tiny kitchenette that can be used to prepare a hot meal.

Truly, this is one of the most impressive off-grid luxury tiny homes we’ve ever seen.

 

Credit: Nice Architects

In the egg-spaced shape measuring 4.5 meters (14.6 feet) in length, 2.4 meters (7.9 feet) in width, and 2.5 meters in height (8.2 feet), there seems to be enough space to compactly fit all the home necessities.

The total usable floor space is eight square meters (86 square feet), enough space, say the designers, to comfortably fit two adults. The home with a tiny footprint includes a folding bed, two large operable windows, a working/dining area, shower and flushable toilet, storage space, and a built-in kitchenette with running water.

Credit: Nice Architects

Credit: Nice Architects

The built-in 750W wind turbine and 2.6-square-meter array of high efficiency solar cells (600W output) power the Ecocapsule. A dual-power system and high-capacity battery (9,744Wh capacity) ensures the rounded shell stays operable even during times of low solar and wind activity.

In addition, the high-tech shelter is optimized for rainwater collection. Each Ecocapsule weighs approximately 1,5000 kilograms and can fit inside a standard shipping container.

 

Credit: Nice Architects

While you’re not alone in your desire to quickly order an Ecocapsule, they are not yet for sale. At present, only renderings and diagrams of the Ecocapsule are available; however, Nice Architects plans to unveil a prototype at the Pioneers festival in Vienna on May 28, 2015.

Having taken seven years to complete the wondrous Ecocapsule, the Nice Architects plans to release the tiny home for sale later this year. The first produced units are planned to be delivered in the first half of 2016.

As shown below, maybe it could also be a sustainable solution for those who currently live without a safe, secure home?

 

Credit: Nice Architects

HOMO NALEDI: NEW HUMAN ANCESTOR DISCOVERED


Within a deep and narrow cave in South Africa, paleoanthropologist Lee Berger and his team found fossil remains belonging to the newest member of our human family. The Homo naledi discovery adds another exciting chapter to the human evolution story by introducing an ancestor that was primitive but shared physical characteristics with modern humans.

Because the cave system where the bones were located was extremely difficult to access, it could be speculated that these hominins practiced a behavior previously believed to be modern: that of deliberately disposing of their dead underground.

Watch the video. URL:https://youtu.be/oxgnlSbYLSc

Frozen embryos are now as successful as fresh embryos in IVF treatments.


Success rates in IVF cycles using frozen and thawed embryos are now equal to those using fresh embryos, a new report on reproductive technology (ART) treatments in Australia and New Zealand has found.

In the five years leading up to 2013, the birth rate for frozen embryo transfers grew by a quarter to 23 percent, whereas the rate of fresh embryo IVF cycles that led to a baby remained steady, also at 23 percent. Effectively, both methods now offer equal chances of a successful birth for parents looking into IVF.

 

In addition to success rates for frozen embryos rising, Australian and New Zealand parents are also turning to the technique in greater numbers, with IVF treatments using frozen embryos increasing from 39 percent of IVF cycles in 2009 to 45 percent in 2013.

The figures are contained in the Assisted Reproductive Technology in Australia and New Zealand 2013 report, authored by researchers at the University of New South Wales (UNSW) in Australia.

“Rapid freezing techniques, known as vitrification, and optimisation of the timing of embryo transfer have made a real difference to the success of frozen embryo birth rates,” said Michael Chapman, a professor of obstetrics and gynaecology at UNSW and vice-president of the Fertility Society of Australia (FSA), in a press release.

“Other techniques, such as culturing embryos for five to six days to a blastocyst, before transfer to a woman, and the use of pre-implantation genetic screening have also increased over the last five years of reporting,” said Chapman.

Another significant trend observed in the figures is a marked reduction in multiple births in IVF treatments, which have decreased by a third in the past five years to 5.6 percent in 2013.

Multiple births result in the delivery of twins, triplets, or higher-order multiples. As women age, they are more likely to experience multiple births, as their bodies may release more than one egg in order to fall pregnant – and the likelihood of multiple births is also significantly increased by the use of IVF and fertility treatments. However, delivering multiple babies can be dangerous to both a mother and her infants.

“Multiple births are by far the greatest health risk to mothers and babies from IVF, and multiple embryo transfer clearly increases this risk,” said Chapman. “This is one of the lowest rates of multiple deliveries from IVF treatment in the world.”

By comparison, the multiple birth rate is 16 percent in the UK and 26 percent in the US.

According to Chapman, the new figures suggest that Australia and New Zealand are the safest regions in the world for women to undergo IVF treatments. “Australia and New Zealand have the lowest IVF multiple birth rates of any region in the world,“ he said, ”and yet also maintain consistently high success rates.”

System can convert MRI heart scans into 3D-printed, physical models in a few hours


System can convert MRI heart scans into 3D-printed, physical models in a few hours
New system from MIT and Boston Children’s Hospital researchers converts MRI scans into 3D-printed heart models (shown here). Credit: Bryce Vickmark

Researchers at MIT and Boston Children’s Hospital have developed a system that can take MRI scans of a patient’s heart and, in a matter of hours, convert them into a tangible, physical model that surgeons can use to plan surgery.

The models could provide a more intuitive way for surgeons to assess and prepare for the anatomical idiosyncrasies of individual patients. “Our collaborators are convinced that this will make a difference,” says Polina Golland, a professor of and computer science at MIT, who led the project. “The phrase I heard is that ‘surgeons see with their hands,’ that the perception is in the touch.”

This fall, seven cardiac surgeons at Boston Children’s Hospital will participate in a study intended to evaluate the models’ usefulness.

Golland and her colleagues will describe their new system at the International Conference on Medical Image Computing and Computer Assisted Intervention in October. Danielle Pace, an MIT graduate student in electrical engineering and computer science, is first author on the paper and spearheaded the development of the software that analyzes the MRI scans. Medhi Moghari, a physicist at Boston Children’s Hospital, developed new procedures that increase the precision of MRI scans tenfold, and Andrew Powell, a cardiologist at the hospital, leads the project’s clinical work.

The work was funded by both Boston Children’s Hospital and by Harvard Catalyst, a consortium aimed at rapidly moving scientific innovation into the clinic.

MRI data consist of a series of cross sections of a three-dimensional object. Like a black-and-white photograph, each cross section has regions of dark and light, and the boundaries between those regions may indicate the edges of anatomical structures. Then again, they may not.

Determining the boundaries between distinct objects in an image is one of the central problems in computer vision, known as “image segmentation.” But general-purpose image-segmentation algorithms aren’t reliable enough to produce the very precise models that surgical planning requires.

Human factors

Typically, the way to make an image-segmentation algorithm more precise is to augment it with a generic model of the object to be segmented. Human hearts, for instance, have chambers and blood vessels that are usually in roughly the same places relative to each other. That anatomical consistency could give a segmentation algorithm a way to weed out improbable conclusions about object boundaries.

System can convert MRI heart scans into 3D-printed, physical models in a few hours
New system from MIT and Boston Children’s Hospital researchers converts MRI scans into 3D-printed heart models (shown here). Credit: Bryce Vickmark

The problem with that approach is that many of the cardiac patients at Boston Children’s Hospital require surgery precisely because the anatomy of their hearts is irregular. Inferences from a generic model could obscure the very features that matter most to the surgeon.

In the past, researchers have produced printable models of the heart by manually indicating boundaries in MRI scans. But with the 200 or so cross sections in one of Moghari’s high-precision scans, that process can take eight to 10 hours.

“They want to bring the kids in for scanning and spend probably a day or two doing planning of how exactly they’re going to operate,” Golland says. “If it takes another day just to process the images, it becomes unwieldy.”

Pace and Golland’s solution was to ask a human expert to identify boundaries in a few of the cross sections and allow algorithms to take over from there. Their strongest results came when they asked the expert to segment only a small patch —one-ninth of the total area—of each .

In that case, segmenting just 14 patches and letting the algorithm infer the rest yielded 90 percent agreement with expert segmentation of the entire collection of 200 cross sections. Human segmentation of just three patches yielded 80 percent agreement.

“I think that if somebody told me that I could segment the whole heart from eight slices out of 200, I would not have believed them,” Golland says. “It was a surprise to us.”

Together, human segmentation of sample patches and the algorithmic generation of a digital, 3-D heart model takes about an hour. The 3-D-printing process takes a couple of hours more.

System can convert MRI heart scans into 3D-printed, physical models in a few hours
New system from MIT and Boston Children’s Hospital researchers converts MRI scans into 3D-printed heart models (shown here). Credit: Bryce Vickmark

Prognosis

Currently, the algorithm examines patches of unsegmented cross sections and looks for similar features in the nearest segmented cross sections. But Golland believes that its performance might be improved if it also examined patches that ran obliquely across several cross sections. This and other variations on the algorithm are the subject of ongoing research.

The clinical study in the fall will involve MRIs from 10 patients who have already received treatment at Boston Children’s Hospital. Each of seven surgeons will be given data on all 10 patients—some, probably, more than once. That data will include the raw MRI scans and, on a randomized basis, either a or a computerized 3-D model, based, again at random, on either human segmentations or algorithmic segmentations.

Using that data, the surgeons will draw up surgical plans, which will be compared with documentation of the interventions that were performed on each of the patients. The hope is that the study will shed light on whether 3-D-printed physical models can actually improve surgical outcomes.

“Absolutely, a 3-D model would indeed help,” says Sitaram Emani, a cardiac surgeon at Boston Children’s Hospital who is not a co-author on the new paper. “We have used this type of model in a few patients, and in fact performed ‘virtual surgery’ on the heart to simulate real conditions. Doing this really helped with the real surgery in terms of reducing the amount of time spent examining the heart and performing the repair.”

“I think having this will also reduce the incidence of residual lesions—imperfections in repair—by allowing us to simulate and plan the size and shape of patches to be used,” Emani adds. “Ultimately, 3D-printed patches based upon the model will allow us to tailor prosthesis to patient.”

“Finally, having this immensely simplifies discussions with families, who find the anatomy confusing,” Emani says. “This gives them a better visual, and many patients and families have commented on how this empowers them to understand their condition better.”

French startup claims development of in-vitro human sperm.


French researchers Philippe Durand, left, in charge of sciences at Kalistem startup, Marie-Helene Perrard, co-founder of Kalistem and Laurent David, a scientist at Lyon University, pose at the elite scientific university of Lyon (ENS), central France, Thursday, Sept. 17, 2015. A French startup working with a top government lab says it has developed in-vitro human sperm, claiming a breakthrough in infertility treatment sought for more than a decade. (AP Photo/Laurent Cipriani)

A French startup working with a top government lab said it has developed in-vitro human sperm, claiming a breakthrough in infertility treatment sought for more than a decade.

Researchers with Kallistem had announced the discovery previously, but they and French government lab CNRS described how it works for the first time Thursday after taking out a patent on the process.

They have developed sperm from immature cells known as spermatogonial cells, which are present in all males, including pre-pubescent boys, and under normal conditions develop into sperm cells once puberty starts. The technology must now be clinically tested, a process that is particularly painstaking for any treatment involving reproduction.

Philippe Durand, the chief Kallistem researcher, said the genesis of the research was indications that male fertility was declining, which he said could be attributed to environmental factors.

Since “at the heart of the problem is the interior of the testicle,” he said, that was what they first tried to replicate in the lab.

The research team developed a bioreactor using a viscous fluid made partly of substances found in the walls of mushrooms or in crustacean shells to reproduce the conditions within the body. They first used rat cells, then young monkey cells, then finally human cells.

The main challenge was reproducing in the lab a complex physiological development process that usually lasts 72 days in a human, from immature cell to sperm.

French startup claims development of in-vitro human sperm (Update)
French researchers Philippe Durand, left, in charge of sciences at Kalistem startup, Marie-Helene Perrard, co-founder of Kalistem and Laurent David, a scientist at Lyon University, pose at the elite scientific university of Lyon (ENS), central France, Thursday, Sept. 17, 2015. A French startup working with a top government lab says it has developed in-vitro human sperm, claiming a breakthrough in infertility treatment sought for more than a decade. (AP Photo/Laurent Cipriani)

In each case, “they took the entire path they would have taken in the testicle in our in-vitro system,” said Durand, who worked with colleagues at CNRS and the elite Lyon 1 university.

CNRS researcher Marie-Helen Perrard, who also helped found Kallistem, said young men with cancer that could cause fertility issues later in their lives would be the first type of patient who could be helped by the process. She said their fertility could be preserved by developing mature sperm from their immature cells, then freezing it.

The research team said the technology could help treat issues affecting 15,000 young cancer patients and 120,000 men worldwide whose infertility cannot be treated any other way.

French startup claims development of in-vitro human sperm (Update)
A technician examines specimens at the elite scientific university of Lyon (ENS), central France, Thursday, Sept. 17, 2015. A French startup working with a top government lab says it has developed in-vitro human sperm, claiming a breakthrough in infertility treatment sought for more than a decade. (AP Photo/Laurent Cipriani)

Ultimately, it has the potential to be a significant addition to infertility treatments that often bypass men altogether, said Liberty Barnes, a research associate at the University of Cambridge and author of a book on male infertility who has no connection to the work being done in France.

As many as 15 percent of couples are infertile, according to the Mayo Clinic. Barnes said men and women each account for about 30 percent of infertility cases, with a combination of factors accounting for the remaining 40 percent.

“As a culture we presume that when a couple is infertile it’s a woman’s problem,” Barnes said. “Infertile men are disappointed that there aren’t more options for them.”

French startup claims development of in-vitro human sperm (Update)
This photo provided Thursday Sept. 17, 2015 by the the National Center of Scientific Research (CNRS) shows a human round spermatid. A French start-up working in conjunction with a top government lab say they have developed in-vitro human sperm, claiming a breakthrough in infertility treatment sought for more than a decade. (M-H Perrard, CNRS/Kallistem via AP)
French startup claims development of in-vitro human sperm (Update)
This photo provided Thursday Sept. 17, 2015 by the the National Center of Scientific Research (CNRS) shows one human round spermatid associated with spermatocytes. A French start-up working in conjunction with a top government lab say they have developed in-vitro human sperm, claiming a breakthrough in infertility treatment sought for more than a decade. (M-H Perrard, CNRS/Kallistem via AP)
French startup claims development of in-vitro human sperm (Update)
This photo provided Thursday Sept. 17, 2015 by the the National Center of Scientific Research (CNRS) shows a human spermatozoon. A French start-up working in conjunction with a top government lab say they have developed in-vitro human sperm, claiming a breakthrough in infertility treatment sought for more than a decade.